Immunological detection using two detectable labels

• US 5,723,304 A
• Filed: 02/27/1995
• Issued: 03/03/1998
• Est. Priority Date: 08/03/1992
• Status: Expired due to Fees

• Current Assignee: Marconi Caswell Limited (Marconi Holdings Company Limited)
• Original Assignee: GEC Marconi Limited (Gooding Consumer Electronics Ltd.)
• Inventors: Abuknesha, Ramadan Arbi
• Primary Examiner(s): HUFF, SHEELA JITENDRA
• Application Number:
  US08/381,826
• Time in Patent Office: 1,100 Days
• Field of Search: 435/4, 435/7.1, 435/7.2, 435/7.5, 435/7.9, 435/7.91, 435/7.92-7.95, 435/40.5, 435/174-181, 435/960, 435/972, 436/518, 436/523, 436/524, 436/527-534, 436/536
• US Class Current: 435/7.9
• CPC Class Codes: G01N 2474/20 Immunohistochemistry assay
• CPC Class Codes: G01N 33/54353 with ligand attached to the carrier via a chemical coupling agent coatings G01N33/54393
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/581 with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: Y10S 435/972 Modified antibody, e.g. hybrid, bifunctional

Abstract

The invention relates to a method of detection, a sensor and a test-kit which find application in immunological detection (e.g., immunoassay). The invention provides, inter alia, a method of detection, suitable for use in immunological detection of an entity, which method includes the use of a secondary species (as defined in the specification), the use of a first detectable species, and the use of a second detectable species. The method may include, for example, the use of a primary species, a secondary species, a first detectable species and a second detectable species. The primary species may be, for example, an antibody or a ligand. The secondary species may be, for example, an auxiliary species such as an auxiliary binder or an auxiliary ligand, or a species which has a part which is an auxiliary function. The entity to be detected may be an analyte species as such or may be an entity which carries or includes analytes species.

Claims

1. In a competitive assay method for immunological detection in a sample of the presence or concentration of an analyte species, wherein (a) a primary species comprises an analyte analog;

(b) the primary species provides or is associated with a first detectable species;

(c) a primary species reaction partner is provided which is capable of undergoing a specific binding reaction in a primary immune reaction mixture with the analyte species, if present, or with the analyte analog;

(d) both the sample and the primary species are exposed to and incubated with the primary species reaction partner;

(e) means are provided for separating the primary species from the reaction mixture; and

(f) a signal from the first detectable species is detected by a signal-detecting means, the improvement comprising;

(i) causing a second detectable specics to become associated with a support material via a secondary species and a secondary species reaction partner, said secondary species (A) being a species which does not itself undergo a specific binding reaction with the analyte species or with the analyte analog, (B) providing or being associated with the second detectable species, (C) undergoing a specific binding reaction with the secondary species reaction partner which is provided on or by, or associated with, the support material, and (D) being or becoming linked to the primary species reaction partner; and

(ii) if the analyte analog becomes bound to the primary species reaction partner, causing the first detectable species to become associated with the support material via linkage of the primary species reaction partner to the secondary species, with signals from said first and second detectable species being detectable by the signal detection means independently of each other and without interference one with another,

whereby quantitative comparison of the respective signal levels detected from the first and second detectable species enables ratiometric detection of the analyte species.

5. The improvement as claimed in claims 1, 2 or 3 wherein the primary species is a primary antibody or a ligand.

6. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species is an antibody for an antigenic species.

7. The improvement as claimed in claim 6 wherein the antibody is selected from the group consisting of anti-2,4 dinitrophenol antibody, anti-fluorescein antibody, anti-digitoxin antibody, anti-coumarin antibody, anti-cibacron blue antibody, anti-2-(4-aminophenyl)-6-methyl benzothiazole-hemiglutarate antibody, anti-camphorcarboxylic acid antibody, anti-4-amino-benzo-15-crown-5 antibody, anti-carboxyfluorescein antibody, anti-3-methyl-1-adamantane acetic acid antibody, anti-2-phenyl-4-quinoline carboxylic acid antibody, anti-xanthine-9-carboxyamide-glycine-glycine antibody, anti-4-hydroxy-7-trifluorcmethyl-3-quinaldine carboxylic acid antibody, anti-cis-bicyclo 3,3,0! octane-2-carboxylic acid antibody, anti-endo-bicyclo 2,2,2! oct-5-ene-2,3-dicarboxylic anhydride antibody, anti-N- 4-(4-aminobenzyl) phenyl!-5-norbornene-2,3-dicarboximide antibody, and anti- IR-(2-endo, 3-exo)!-3-hydroxy-4,7,7-trimethyl bicyclo 2,2,1! heptane-2-acetic acid antibody.

8. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species is a binder for a non-antigenic ligand.

9. The improvement as claimed in claim 8 wherein the binder is avidin.

10. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species is an antigenic ligand.

11. The improvement as claimed in claim 10 wherein the antigenic ligand is selected from the group consisting of 2,4 dinitrophenol, fluorescein, digitoxin, coumarin, cibacron blue, 2-(4-aminophenyl)-6-methyl benzothiazole-hemiglutarate, camphorcarboxylic acid, 4-amino-benzo-15-crown-5, carboxyfluorescein, 3-methyl-1-adamantane acetic acid, 2-phenyl-4-quinoline carboxylic acid, xanthine-9-carboxyamide-glycine-glycine, 4-hydroxy-7-trifluoromethyl-3-quinaldine carboxylic acid, cis-bicyclo 3,3,0! octane-2-carboxylic acid, endo-bicyclo 2,2,2! oct-5-ene-2,3-dicarboxylic anhydride, N- 4-(4-aminobenzyl) phenyl!-5-norbornene-2,3-dicarboximide, and IR-(2-endo, 3-exo)!-3-hydroxy-4,7,7-trimethyl bicyclo 2,2,1! heptane-2-acetic acid.

12. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species is a non-antigenic ligand.

13. The improvement as claimed in claim 12 wherein the ligand is biotin.

14. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species is a bifunctional antibody.

15. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species reaction partner is selected from the group consisting of anti-2,4 dinitrophenol antibody, anti-fluorescein antibody, anti-digitoxin antibody, anti-coumarin antibody, anti-cibacron blue antibody, anti-2-(4-aminophenyl)-6-methyl benzothiazole-hemiglutarate antibody, anti-camphorcarboxylic acid antibody, anti-4-amino-benzo-15-crown-5 antibody, anti-carboxyfluorescein antibody, anti-3-methyl-1-adamantane acetic acid antibody, anti-2-phenyl-4-quinoline carboxylic acid antibody, anti-xanthine-9-carboxyamide-glycine-glycine antibody, anti-4-hydroxy-7-trifluoromethyl-3-quinaldine carboxylic acid antibody, anti-cis-bicyclo 3,3,0! octane-2-carboxylic acid antibody, anti-endo-bicyclo 2,2,2! oct-5-ene-2,3-dicarboxylic anhydride antibody, anti-N- 4-(4-aminobenzyl) phenyl!-5-norbornene-2,3-dicarboximide antibody, anti- IR-(2-endo, 3-exo)!-3-hydroxy-4,7,7-trimethyl bicyclo 2,2,1! heptane-2-acetic acid antibody, 2,4-dinitrophenol, fluorescein, digitoxin, coumarin, cibacron blue, 2-(4-aminophenyl)-6-methyl benzothiazole-hemiglutarate, camphorcarboxylic acid, 4-amino-benzo-15-crown-5, carboxyfluorescein, 3-methyl-1-adamantane acetic acid, 2-phenyl-4-quinoline carboxylic acid, xanthine-9-carboxyamide-glycine-glycine, 4-hydroxy-7-trifluoromethyt-3-quinaldine carboxylic acid, cis-bicyclo 3,3,0! octane-2-carboxylic acid, endo-bicyclo 2,2,2! oct-5-ene-2,3-dicarboxylic anhydride, N- 4-(4-aminobenzyl) phenyl!-5-norbornene-2,3-dicarboximide, and IR-(2-endo, 3-exo)!-3-hydroxy-4,7,7-trimethyl bicyclo 2,2,1! heptane-2-acetic acid.

16. The improvemement as claimed in claims 1, 2 or 3 wherein the support material is a reaction vessel wall, an insoluble polysaccharide, a microparticle, polystyrene, cross-linked dextran, an insoluble polymer structure, a glass surface, a derivatised silica surface, a polymer attached to a surface, a magnetisable particle, nylon or a polyamide.

17. A method as claimed in claims 1, 2 or 3 wherein the support material is in the form of a carrier which may be moved from a sample application means for applying a sample to the carrier, to a detection means thereby to allow successive detection of analyte species.

18. The improvement as claimed in claims 1 2 or wherein the primary species reaction partner is an antibody or an antigenic species.

19. The improvement as claimed in claims 1, 2 or 3 wherein the first detectable species is selected from the group consisting of an enzyme, a species capable of giving a fluorescent signal, a chemiluminescent compound, a bioluminescent compound, a radioisotope, a dye, a ligand, a polymer of a ligand, a binder and a polymer of a binder.

20. The improvement as claimed in claim 19 wherein the enzyme is selected from the group consisting of alkaline phosphatase, β

-galactosidase and horse-radish peroxidase.

21. The improvement as claimed in claim 19 wherein the species capable of giving a fluorescent signal is a fluorophore or a polymeric fluorophore.

22. The improvement as claimed in claim 21 wherein the fluorophore is selected from the group consisting of a fluorescein, a coumarin and rhodamine.

23. The improvement as claimed in claims 1, 2 or 3 wherein the second detectable species is selected from the group consisting of an enzyme, a species capable of giving a fluorescent signal, a chemiluminescent compound, a bioluminescent compound, a radioisotope, a dye, a ligand, a polymer of a ligand, a binder and a polymer of a binder.

24. The improvement as claimed in claim 23 wherein the second detectable species (a) is selected from the group consisting of a ligand, a polymer of a ligand, a binder and a polymer of a binder, and (b) has a tracer species associated therewith.

25. The improvement as claimed in claim 24 wherein the tracer species is selected from the group consisting of an enzyme, a fluorophore, a chemiluminescent compound, a bioluminescent compound, a radioisotope and a dye.

26. The improvement as claimed in claims 1, 2 or 3 wherein the analyte species is selected from the group consisting of a steroid hormone, a thyroid hormone, a steroid in an extract, a drug, a polypeptide hormone, a protein antigen, a tumour marker, a blood protein, a marker protein, a pesticide, a toxin, a micro-organism, an antibody to a micro-organism, and a metal complex.

27. The improvement as claimed in claim 26 wherein the metal complex is methyl mercury.

28. The improvement as claimed in claim 26 wherein the analyte species is a metal ion.

29. The improvement as claimed in claims 1, 2 or 3 wherein the method for immunological detection is designed to detect more than one analyte species.

30. The improvement as claimed in claims 1, 2 or 3 wherein the secondary species, the first detectable species, the second detectable species, the primary species or the secondary species reaction partner are prepared in reconstitutable form.

31. A method as claimed in claims 1, 2 or 3 wherein one species selected from the group consisting of the secondary species and the secondary species reaction partner is not capable of undergoing a specific binding reaction with the other species of said group, but may be converted to a species which is capable of undergoing a specific binding reaction with said other species.

2. In a competitive assay method for immunological detection in a sample of the presence or concentration of an analyte species, wherein (a) a primary species provides or is associated with a first detectable species;

(b) a primary species reaction partner is provided which comprises an analyte analog;

(c) the primary species is capable of undergoing a specific binding reaction in a primary immune reaction mixture with the analyte species, if present, or with the primary species reaction partner;

(d) both the sample and the primary species reaction partner are exposed to and incubated with the primary species;

(e) means are provided for separating the primary species reaction partner from the reaction mixture; and

(f) a signal from said first detectable species is detected by a signal-detecting means, the improvement comprising;

(i) causing a second detectable species to become associated with a support material via a secondary species and a secondary species reaction partner, said secondary species (A) being a species which does not itself undergo a specific binding reaction with the analyte species or with the analyte analog, (B) providing or being associated with the second detectable species, (C) undergoing a specific binding reaction with the secondary species reaction partner which is provided on or by, or associated with, the support material, and (D) being or becoming linked to the primary species reaction partner; and

(ii) If the primary species becomes bound to the analyte analog, causing the first detectable species to become associated with the support material via linkage of the primary species reaction partner to the secondary species, with signals from said first and second detectable species being detectable by the signal detection means independently of each other and without interference one with another,

whereby quantitative comparison of the respective signal levels detected from the first and second detectable species enables ratiometric detection of the analytic species.

3. In a non-competitive assay method for immunological detection in a sample of the presence or concentration of an analyte species, wherein (a) a primary species is exposed to and incubated with the sample, (b) the primary species undergoes a specific binding reaction with the analyte species, if present in the sample, in a primary immune reaction mixture, (c) a developing species undergoes a specific binding reaction with the analyte species, if present in the sample;

(d) the developing species provides or is associated with a first detectable species, (e) means are provided for separating the primary species from the reaction mixture, and (f) a signal from said first detectable species is detected by a signal-detecting means, the improvement comprising;

(i) causing a second detectable species to become associated with a support material via a second species and a secondary species reaction partner, said secondary species (A) being a species which does not itself undergo a specific binding reaction with the analyte species, (B) providing or being associated with the second detectable species, (C) undergoing a specific binding reaction with the secondary species reaction partner which is provided on or by, or associated with, the support material, and (D) capable of becoming linked to the primary species; and

(ii) if the analyte species is present in the sample, causing the first detectable species to become associated with the support material via specific binding of the developing species to the analyte species, specific binding of the analyte species to the primary species and linkage of the primary species to the secondary species, with signals from said first and second detectable species being detectable by the signal detection means independently of each other and without interference one with another,

whereby quantitative comparison of the respective signal levels detected from the first and second detectable species enables ratiometric detection of the analyte species.

4. A test kit suitable for use in immunological detection in a sample of the presence or concentration of an analyte species, said test kit comprising:

(a) a primary species, said primary species or a reaction partner therefor capable of undergoing a specific binding reaction with the analyte species;

(b) a first detectable species provided (i) on or by, or associated with, said primary species, or (ii) on or by, or associated with, a developing species capable of undergoing a specific binding reaction with the analyte species;

(c) a secondary species being a species which does not itself undergo a specific binding interaction with the analyte species;

(d) a second detectable species provided on or by, or associated with, said secondary species; and

(e) a secondary species reaction partner provided on or by, or capable of becoming associated with, a support material,

whereby when the test kit is in use the second detectable species becomes associated with the support material via specific binding of the secondary species to the secondary species reaction partner, and the first detectable species is capable of becoming associated with the support material via linkage of the primary species to the secondary species, with signals from said first and second detectable species being detectable by the signal detection means independently of each other and without interference one with another.